Award
NIH Reporter #5U01AI182035-03
Development of a Chimeric Syphilis Vaccine Candidate to Combat Local, Disseminated and Congenital Syphilis Infection
Recipient
University of Victoria
Award Amount
$1,594,456.00
Ceiling
$1,594,456.00
Awarded
April 17, 2026
Identifier
5U01AI182035-03
NIH awarded a grant to the University of Victoria to develop a chimeric syphilis vaccine candidate, focusing on preclinical studies to enhance vaccine efficacy and readiness for clinical trials.
Description
This project aims to develop a chimeric syphilis vaccine candidate through IND-enabling preclinical studies including immunoreactivity, protection assessment, formulation optimization, toxicity, stability, and scale-up compatibility to prepare for clinical trials.